South Korea · Delayed Price · Currency is KRW Sam-A Pharm. Statistics
Total Valuation
Sam-A Pharm. has a market cap or net worth of KRW 81.72 billion. The enterprise value is -15.05 billion.
| Market Cap | 81.72B |
| Enterprise Value | -15.05B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Sam-A Pharm. has 6.10 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 6.10M |
| Shares Outstanding | 6.10M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 68.45% |
| Owned by Institutions (%) | n/a |
| Float | 1.93M |
Valuation Ratios
The trailing PE ratio is 9.20.
| PE Ratio | 9.20 |
| Forward PE | n/a |
| PS Ratio | 1.15 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | 10.18 |
| P/OCF Ratio | 8.41 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.69 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.87 |
Financial Position
The company has a current ratio of 7.79, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.79 |
| Quick Ratio | 6.86 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.55 |
| Debt / FCF | 0.67 |
| Interest Coverage | 12.75 |
Financial Efficiency
Return on equity (ROE) is 3.97% and return on invested capital (ROIC) is 3.57%.
| Return on Equity (ROE) | 3.97% |
| Return on Assets (ROA) | 1.39% |
| Return on Invested Capital (ROIC) | 3.57% |
| Return on Capital Employed (ROCE) | 2.44% |
| Weighted Average Cost of Capital (WACC) | 5.20% |
| Revenue Per Employee | 232.55M |
| Profits Per Employee | 29.14M |
| Employee Count | 305 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.94 |
Taxes
In the past 12 months, Sam-A Pharm. has paid 1.61 billion in taxes.
| Income Tax | 1.61B |
| Effective Tax Rate | 15.38% |
Stock Price Statistics
The stock price has decreased by -26.14% in the last 52 weeks. The beta is 0.15, so Sam-A Pharm.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -26.14% |
| 50-Day Moving Average | 15,682.20 |
| 200-Day Moving Average | 16,221.80 |
| Relative Strength Index (RSI) | 26.23 |
| Average Volume (20 Days) | 10,799 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sam-A Pharm. had revenue of KRW 70.93 billion and earned 8.89 billion in profits. Earnings per share was 1,455.84.
| Revenue | 70.93B |
| Gross Profit | 40.22B |
| Operating Income | 5.62B |
| Pretax Income | 10.50B |
| Net Income | 8.89B |
| EBITDA | 9.81B |
| EBIT | 5.62B |
| Earnings Per Share (EPS) | 1,455.84 |
Balance Sheet
The company has 102.19 billion in cash and 5.41 billion in debt, with a net cash position of 96.78 billion or 15,856.40 per share.
| Cash & Cash Equivalents | 102.19B |
| Total Debt | 5.41B |
| Net Cash | 96.78B |
| Net Cash Per Share | 15,856.40 |
| Equity (Book Value) | 225.89B |
| Book Value Per Share | 36,978.43 |
| Working Capital | 120.22B |
Cash Flow
In the last 12 months, operating cash flow was 9.72 billion and capital expenditures -1.69 billion, giving a free cash flow of 8.03 billion.
| Operating Cash Flow | 9.72B |
| Capital Expenditures | -1.69B |
| Depreciation & Amortization | 4.19B |
| Net Borrowing | -6.26B |
| Free Cash Flow | 8.03B |
| FCF Per Share | 1,315.46 |
Margins
Gross margin is 56.70%, with operating and profit margins of 7.93% and 12.53%.
| Gross Margin | 56.70% |
| Operating Margin | 7.93% |
| Pretax Margin | 14.81% |
| Profit Margin | 12.53% |
| EBITDA Margin | 13.83% |
| EBIT Margin | 7.93% |
| FCF Margin | 11.32% |
Dividends & Yields
This stock pays an annual dividend of 850.00, which amounts to a dividend yield of 6.58%.
| Dividend Per Share | 850.00 |
| Dividend Yield | 6.58% |
| Dividend Growth (YoY) | 6.25% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 54.94% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 6.21% |
| Earnings Yield | 10.87% |
| FCF Yield | 9.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 29, 2008. It was a forward split with a ratio of 1.02005.
| Last Split Date | Dec 29, 2008 |
| Split Type | Forward |
| Split Ratio | 1.02005 |
Scores
Sam-A Pharm. has an Altman Z-Score of 4.84 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.84 |
| Piotroski F-Score | 5 |